<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02651428</url>
  </required_header>
  <id_info>
    <org_study_id>LOCK-IT-100</org_study_id>
    <nct_id>NCT02651428</nct_id>
  </id_info>
  <brief_title>Study Assessing Safety &amp; Effectiveness of a Catheter Lock Solution in Dialysis Patients to Prevent Bloodstream Infection</brief_title>
  <official_title>Phase 3 Prospective, Multicenter, Double-blind, Randomized, Active Control Study to Demonstrate Safety &amp; Effectiveness of Neutrolin in Preventing Catheter-related Bloodstream Infection in Subjects on Hemodialysis for End Stage Renal Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CorMedix</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>PPD</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>JMI Laboratories</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Spectra Clinical Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Davita Clinical Research</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Frenova Renal Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>CorMedix</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is determine safety and effectiveness of Neutrolin, a catheter lock&#xD;
      solution, for prevention of central venous catheter associated bloodstream infection in&#xD;
      hemodialysis patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to demonstrate the efficacy and safety of Neutrolin® as a&#xD;
      catheter lock solution (CLS) on prevention of catheter-related bloodstream infection (CRBSI),&#xD;
      and the incidence of treatment-emergent adverse events in subjects receiving hemodialysis&#xD;
      (HD) for the treatment of End Stage Renal Disease (ESRD) when compared with heparin 4,000 USP&#xD;
      Units/4mL (1,000 USP Units/mL).&#xD;
&#xD;
      This is a randomized, double-blind, active control, parallel-arm, multicenter study. Six&#xD;
      hundred and thirty two subjects will be randomized in a 1:1 ratio to receive either&#xD;
      Neutrolin® or the active control heparin (Heparin sodium USP 1,000 units/mL, Benzyl alcohol&#xD;
      9.45 mg/mL and Sodium chloride 9.0 mg/mL) as a CLS.&#xD;
&#xD;
      Approximately 632 randomized subjects are planned for this trial. In this study, one-half of&#xD;
      the subjects (316 subjects) will receive Neutrolin as a study drug and the other half will&#xD;
      receive heparin 4,000 USP Units/4mL (1,000 USP Units/mL) with benzyl alcohol preservative as&#xD;
      a comparator. Subjects will be assigned in a 1:1 ratio using permuted blocks without&#xD;
      additional stratification for both groups.&#xD;
&#xD;
      The primary objective of this study is to demonstrate the effectiveness of Neutrolin® as a&#xD;
      CLS in ESRD subjects undergoing HD treatment using a permanent, cuffed, tunneled silicone or&#xD;
      polyurethane HD catheter. The study will evaluate whether Neutrolin® is superior to the&#xD;
      active control heparin by documenting the time to CRBSI and consequently delaying the time&#xD;
      until the occurrence of CRBSI.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Actual">October 2018</completion_date>
  <primary_completion_date type="Actual">October 2018</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Presence of a CAC-Adjudicated Catheter-Related Bloodstream Infection (CRBSI) in Subjects Receiving Hemodialysis for the Treatment of End Stage Renal Disease (ESRD): Final Analysis</measure>
    <time_frame>The event time was the number of days from randomization until the occurrence of a CAC-Adjudicated CRBSI or until the subject was censored. The mean participant duration of exposure to study drug was 174 days (range 4-884 days).</time_frame>
    <description>CRBSI was defined as the same organism grown from at least one positive blood culture from a peripheral site or bloodline sample, or either the arterial or venous catheter hub. The final assessment of CRBSI was determined by a Clinical Adjudication Committee (CAC) who used both clinical documentation and blood culture results in their assessment.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Participants With a Study Catheter Removal for Any Reason</measure>
    <time_frame>The event time was the number of days from randomization until catheter removal for any reason or until the subject was censored. The mean participant duration of exposure to study drug was 174 days (range 4-884 days).</time_frame>
    <description>Analysis of all catheter removals during the study or until the catheter was removed</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">806</enrollment>
  <condition>Kidney Failure, Chronic</condition>
  <condition>Catheter-Related Infections</condition>
  <arm_group>
    <arm_group_label>Neutrolin arm</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Neutrolin: Neutrolin will be added to the central venous catheter after dialysis as a lock solution</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Heparin arm</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Heparin: Heparin will be added to the central venous catheter after dialysis as a lock solution</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Neutrolin</intervention_name>
    <description>Neutrolin® will be instilled into central venous HD catheters at the discontinuation of all dialysis sessions and will be withdrawn prior to the initiation of the next dialysis session</description>
    <arm_group_label>Neutrolin arm</arm_group_label>
    <other_name>1.35% taurolidine, 3.5% citrate, heparin 1,000 USP Units/mL</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Heparin</intervention_name>
    <description>Heparin will be instilled into central venous HD catheters at the discontinuation of all dialysis sessions and will be withdrawn prior to the initiation of the next dialysis session</description>
    <arm_group_label>Heparin arm</arm_group_label>
    <other_name>Heparin Sodium</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subject has ESRD and undergoes chronic HD at least two times per week&#xD;
&#xD;
          2. Subject has a HD catheter that has demonstrated the ability to achieve a minimum blood&#xD;
             flow of at least 250 mL/min for at least two consecutive dialysis sessions blood flow&#xD;
             to enable successful HD&#xD;
&#xD;
          3. The HD catheter is implanted with the tip in a jugular or subclavian vein&#xD;
&#xD;
          4. The subject is not expected to expire within 180 days&#xD;
&#xD;
          5. The subject is likely to require the use of a CVC for at least 90 days&#xD;
&#xD;
          6. The subject (or the legal guardian) understands the nature of the study and provides&#xD;
             written informed consent prior to the study enrollment&#xD;
&#xD;
          7. The subject is willing to comply with specified follow-up evaluations and prescribed&#xD;
             dialysis therapy and&#xD;
&#xD;
          8. If female and of childbearing potential, the subject must have a negative pregnancy&#xD;
             test at the screening visit (i.e., subject is not pregnant); not be lactating; and use&#xD;
             an acceptable method of contraception, including abstinence, a barrier method&#xD;
             (diaphragm or condom), Depo-Provera, or hormonal contraceptive (oral, implant, ring,&#xD;
             patch) for the duration of the study. (NOTE: The subject must have used the chosen&#xD;
             method of birth control for at least 1 month/cycle prior to enrollment into the&#xD;
             study).&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Subjects who received antibiotics within the last 14 days&#xD;
&#xD;
          2. Visible evidence of compromised skin integrity is present at the catheter exit site or&#xD;
             evidence of a catheter exit site infection&#xD;
&#xD;
          3. Subject has received any thrombolytic treatment (i.e., tPA) in their current catheter&#xD;
             within 30 days of randomization&#xD;
&#xD;
          4. Fill volume of HD catheter is unknown or cannot be determined&#xD;
&#xD;
          5. Subjects using any type of antimicrobial-coated or heparin-coated catheter&#xD;
&#xD;
          6. Documented chronic bleeding diathesis, active or recurrent bleeding within 1 month&#xD;
             prior to randomization&#xD;
&#xD;
          7. Documented history of an atrial thrombus or known hypercoagulable state&#xD;
&#xD;
          8. Subjects with open, non-healing skin ulcers&#xD;
&#xD;
          9. Current requirement for systemic immunosuppression that would increase risk of&#xD;
             infection&#xD;
&#xD;
         10. Active malignancy requiring or anticipated to require chemotherapy likely to cause&#xD;
             leukopenia and/or immunosuppression&#xD;
&#xD;
         11. Known allergy or absolute contraindication to citrate, taurolidine or heparin or a&#xD;
             history of heparin-induced thrombocytopenia&#xD;
&#xD;
         12. Unstable malignancy&#xD;
&#xD;
         13. Cirrhosis with encephalopathy&#xD;
&#xD;
         14. Subject is currently taking another medication with known systemic drug interaction&#xD;
             with citrate, taurolidine, or heparin&#xD;
&#xD;
         15. Subject is currently enrolled in another investigational device and/or drug trial or&#xD;
             has participated in another investigational device and/or drug trial within 30 days&#xD;
             prior to enrollment&#xD;
&#xD;
         16. Subject is anticipated to receive a renal transplant within 90 days (subjects can be&#xD;
             on the transplant list, but a subject with a known or anticipated transplant date&#xD;
             within the next 90 days should be excluded)&#xD;
&#xD;
         17. Any other medical condition which renders the subject unable to or unlikely to&#xD;
             complete the study, or which would interfere with optimal participation in the study&#xD;
             or produce significant risk to the subject.&#xD;
&#xD;
             -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Antony Pfaffle, MD</last_name>
    <role>Study Director</role>
    <affiliation>Chief Scientific Officer</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Riverside Nephrology Physicians/Van Buren Dialysis center</name>
      <address>
        <city>Riverside</city>
        <state>California</state>
        <zip>92503</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North America Research Institute</name>
      <address>
        <city>San Dimas</city>
        <state>California</state>
        <zip>91773</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>North Beach Dialysis Center Inc.</name>
      <address>
        <city>Miami Gardens</city>
        <state>Florida</state>
        <zip>33169</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Lower Manhattan Dialysis Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Diagnostic Clinic of Houston</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77004</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>January 7, 2016</study_first_submitted>
  <study_first_submitted_qc>January 7, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 11, 2016</study_first_posted>
  <results_first_submitted>April 28, 2021</results_first_submitted>
  <results_first_submitted_qc>August 5, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">August 31, 2021</results_first_posted>
  <disposition_first_submitted>August 4, 2020</disposition_first_submitted>
  <disposition_first_submitted_qc>August 4, 2020</disposition_first_submitted_qc>
  <disposition_first_posted type="Actual">August 7, 2020</disposition_first_posted>
  <last_update_submitted>August 5, 2021</last_update_submitted>
  <last_update_submitted_qc>August 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Kidney Failure, Chronic</keyword>
  <keyword>Catheter-Related Infections</keyword>
  <keyword>Central Venous Catheter</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Sepsis</mesh_term>
    <mesh_term>Catheter-Related Infections</mesh_term>
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Taurolidine</mesh_term>
    <mesh_term>Heparin</mesh_term>
    <mesh_term>Calcium heparin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>October 6, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/28/NCT02651428/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>January 29, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/28/NCT02651428/SAP_001.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Neutrolin Arm</title>
          <description>Neutrolin: Neutrolin will be added to the central venous catheter after dialysis as a lock solution&#xD;
Neutrolin: Neutrolin® will be instilled into central venous HD catheters at the discontinuation of all dialysis sessions and will be withdrawn prior to the initiation of the next dialysis session</description>
        </group>
        <group group_id="P2">
          <title>Heparin Arm</title>
          <description>Heparin: Heparin will be added to the central venous catheter after dialysis as a lock solution&#xD;
Heparin: Heparin will be instilled into central venous HD catheters at the discontinuation of all dialysis sessions and will be withdrawn prior to the initiation of the next dialysis session</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="403"/>
                <participants group_id="P2" count="403"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="359"/>
                <participants group_id="P2" count="359"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="44"/>
                <participants group_id="P2" count="44"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All randomized subjects</population>
      <group_list>
        <group group_id="B1">
          <title>Neutrolin Arm</title>
          <description>Neutrolin: Neutrolin will be added to the central venous catheter after dialysis as a lock solution&#xD;
Neutrolin: Neutrolin® will be instilled into central venous HD catheters at the discontinuation of all dialysis sessions and will be withdrawn prior to the initiation of the next dialysis session</description>
        </group>
        <group group_id="B2">
          <title>Heparin Arm</title>
          <description>Heparin: Heparin will be added to the central venous catheter after dialysis as a lock solution&#xD;
Heparin: Heparin will be instilled into central venous HD catheters at the discontinuation of all dialysis sessions and will be withdrawn prior to the initiation of the next dialysis session</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="403"/>
            <count group_id="B2" value="403"/>
            <count group_id="B3" value="806"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="60.8" spread="14.22"/>
                    <measurement group_id="B2" value="60.9" spread="14.39"/>
                    <measurement group_id="B3" value="60.9" spread="14.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="184"/>
                    <measurement group_id="B2" value="154"/>
                    <measurement group_id="B3" value="338"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="219"/>
                    <measurement group_id="B2" value="249"/>
                    <measurement group_id="B3" value="468"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="5"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="18"/>
                    <measurement group_id="B3" value="33"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="14"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="126"/>
                    <measurement group_id="B2" value="112"/>
                    <measurement group_id="B3" value="238"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="248"/>
                    <measurement group_id="B2" value="262"/>
                    <measurement group_id="B3" value="510"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="403"/>
                    <measurement group_id="B2" value="403"/>
                    <measurement group_id="B3" value="806"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Presence of a CAC-Adjudicated Catheter-Related Bloodstream Infection (CRBSI) in Subjects Receiving Hemodialysis for the Treatment of End Stage Renal Disease (ESRD): Final Analysis</title>
        <description>CRBSI was defined as the same organism grown from at least one positive blood culture from a peripheral site or bloodline sample, or either the arterial or venous catheter hub. The final assessment of CRBSI was determined by a Clinical Adjudication Committee (CAC) who used both clinical documentation and blood culture results in their assessment.</description>
        <time_frame>The event time was the number of days from randomization until the occurrence of a CAC-Adjudicated CRBSI or until the subject was censored. The mean participant duration of exposure to study drug was 174 days (range 4-884 days).</time_frame>
        <population>Full Analysis Population - all subjects randomized and receiving one or more doses of study medication.</population>
        <group_list>
          <group group_id="O1">
            <title>Neutrolin Arm</title>
            <description>Neutrolin: Neutrolin will be added to the central venous catheter after dialysis as a lock solution&#xD;
Neutrolin: Neutrolin® will be instilled into central venous HD catheters at the discontinuation of all dialysis sessions and will be withdrawn prior to the initiation of the next dialysis session</description>
          </group>
          <group group_id="O2">
            <title>Heparin Arm</title>
            <description>Heparin: Heparin will be added to the central venous catheter after dialysis as a lock solution&#xD;
Heparin: Heparin will be instilled into central venous HD catheters at the discontinuation of all dialysis sessions and will be withdrawn prior to the initiation of the next dialysis session</description>
          </group>
        </group_list>
        <measure>
          <title>Presence of a CAC-Adjudicated Catheter-Related Bloodstream Infection (CRBSI) in Subjects Receiving Hemodialysis for the Treatment of End Stage Renal Disease (ESRD): Final Analysis</title>
          <description>CRBSI was defined as the same organism grown from at least one positive blood culture from a peripheral site or bloodline sample, or either the arterial or venous catheter hub. The final assessment of CRBSI was determined by a Clinical Adjudication Committee (CAC) who used both clinical documentation and blood culture results in their assessment.</description>
          <population>Full Analysis Population - all subjects randomized and receiving one or more doses of study medication.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="397"/>
                <count group_id="O2" value="398"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="32"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis was that there was no difference in the survival functions for CRBSI between the two treatments. Based on 80% power to detect a 55% reduction in the risk of CRBSI relative to the control treatment, a 1:1 randomization, a 2-sided log-rank test, one interim analysis using the method of Pocock, and an overall alpha of 0.05, it was determined that 56 CRBSIs would be needed. These are the results of the final analysis.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.0006</p_value>
            <p_value_desc>The threshold significance level at the interim and final statistical analyses for the primary efficacy endpoint was 0.0294.</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>0.29</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.14</ci_lower_limit>
            <ci_upper_limit>0.62</ci_upper_limit>
            <estimate_desc>The numerator for the hazard ratio was the estimated hazard for the Neutrolin treatment arm, and the denominator was the estimated hazard for the Heparin treatment arm.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Participants With a Study Catheter Removal for Any Reason</title>
        <description>Analysis of all catheter removals during the study or until the catheter was removed</description>
        <time_frame>The event time was the number of days from randomization until catheter removal for any reason or until the subject was censored. The mean participant duration of exposure to study drug was 174 days (range 4-884 days).</time_frame>
        <population>Full Analysis Population - all subjects randomized and receiving one or more doses of study medication.</population>
        <group_list>
          <group group_id="O1">
            <title>Neutrolin Arm</title>
            <description>Neutrolin: Neutrolin will be added to the central venous catheter after dialysis as a lock solution&#xD;
Neutrolin: Neutrolin® will be instilled into central venous HD catheters at the discontinuation of all dialysis sessions and will be withdrawn prior to the initiation of the next dialysis session</description>
          </group>
          <group group_id="O2">
            <title>Heparin Arm</title>
            <description>Heparin: Heparin will be added to the central venous catheter after dialysis as a lock solution&#xD;
Heparin: Heparin will be instilled into central venous HD catheters at the discontinuation of all dialysis sessions and will be withdrawn prior to the initiation of the next dialysis session</description>
          </group>
        </group_list>
        <measure>
          <title>Participants With a Study Catheter Removal for Any Reason</title>
          <description>Analysis of all catheter removals during the study or until the catheter was removed</description>
          <population>Full Analysis Population - all subjects randomized and receiving one or more doses of study medication.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="397"/>
                <count group_id="O2" value="398"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="236"/>
                    <measurement group_id="O2" value="225"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <groups_desc>The null hypothesis was that there was no difference in the time until catheter removal for any reason between the two treatments.</groups_desc>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>0.4161</p_value>
            <p_value_desc>The threshold for statistical significance was p &lt; 0.05.</p_value_desc>
            <method>Log Rank</method>
            <param_type>Hazard Ratio (HR)</param_type>
            <param_value>1.08</param_value>
            <ci_percent>95</ci_percent>
            <ci_n_sides>2-Sided</ci_n_sides>
            <ci_lower_limit>0.90</ci_lower_limit>
            <ci_upper_limit>1.29</ci_upper_limit>
            <estimate_desc>The numerator for the hazard ratio was the estimated hazard for the Neutrolin treatment arm, and the denominator was the estimated hazard for the Heparin treatment arm.</estimate_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Through a participant's study completion. The mean participant duration of exposure to study drug was 174 days (range 4-884 days).</time_frame>
      <desc>Adverse events were collected for all participants who received study drug, the Full Analysis Population (n=398 Neutrolin, n=399 Heparin). Subjects who did not receive study medication are not included in the adverse event reporting.</desc>
      <group_list>
        <group group_id="E1">
          <title>Neutrolin Arm</title>
          <description>Neutrolin: Neutrolin will be added to the central venous catheter after dialysis as a lock solution&#xD;
Neutrolin: Neutrolin® will be instilled into central venous HD catheters at the discontinuation of all dialysis sessions and will be withdrawn prior to the initiation of the next dialysis session</description>
        </group>
        <group group_id="E2">
          <title>Heparin Arm</title>
          <description>Heparin: Heparin will be added to the central venous catheter after dialysis as a lock solution&#xD;
Heparin: Heparin will be instilled into central venous HD catheters at the discontinuation of all dialysis sessions and will be withdrawn prior to the initiation of the next dialysis session</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>MeDRA 21.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="18" subjects_at_risk="398"/>
                <counts group_id="E2" subjects_affected="21" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="159" subjects_at_risk="398"/>
                <counts group_id="E2" subjects_affected="167" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="398"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hemorrhagic anemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Heparin-induced thrombocytopenia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Lymphadenitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Nephrogenic anemia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="398"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Normocytic anemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pancytopenia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Thrombocytopenia</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute coronary syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="398"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="398"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Angina unstable</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Atrial tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Cardiac arrest</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Cardiac failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Cardiac failure acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="398"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Cardiac tamponade</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Cardiac valve disease</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Cardio-respiratory arrest</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Cardiomyopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Coronary artery disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Coronary artery occlusion</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Ischemic cardiomyopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Left ventricular failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Mitral valve incompetence</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Myocardial infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Nodal arrhythmia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pericardial effusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pulseless electrical activity</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Supraventricular tachycardia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Congenital, familial and genetic disorders</title>
            <event_list>
              <event>
                <sub_title>Protein C deficiency</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Hyperthyroidism secondary</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Myxoedema</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Eye disorders</title>
            <event_list>
              <event>
                <sub_title>Blindness cortical</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Visual impairment</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Abdominal pain upper</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Ascites</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Colitis ischemic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Diabetic gastroparesis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Dumping syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Duodenal ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Gastric ulcer</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Gastric ulcer hemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Gastritis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Gastrointestinal hemorrhage</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="398"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hematemesis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hemorrhoidal hemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Incarcerated inguinal hernia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Intestinal infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Intestinal ischemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Intestinal obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Large intestine perforation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Lower gastrointestinal hemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Mallory-Weiss syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Esophageal ulcer hemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Esophageal varices hemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Esophagitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Esophagitis ulcerative</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pancreatitis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pancreatitis acute</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Peptic ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Small intestinal obstruction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Upper gastrointestinal hemorrhage</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="398"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Complication associated with device</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Death</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="398"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Drug withdrawal syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Impaired healing</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Multiple organ dysfunction syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Edema peripheral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Biliary diskynesia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Cholangitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Cholecystitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Cholecystitis acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Cholecystitis chronic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Cholelithiasis</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hemobilia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hepatic cirrhosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hepatic failure</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hepatic cholestatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Jaundice</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Jaundice cholestatic</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Hypogammaglobulinemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Abdominal abscess</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Abscess neck</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Appendicitis perforated</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Arteriovenous fistula site infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Arteriovenous graft site infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Bacteremia</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="398"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Bacterial sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Bronchitis bacterial</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Carbuncle</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Catheter site cellulitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="398"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Clostridium difficile colitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Clostridium difficile infection</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Device related infection</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="398"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Device related sepsis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Diabetic foot infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Endocarditis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Endocarditis staphylococcal</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Endophthalmitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Enterococcal bacteremia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Enterococcal infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Escherichia urinary tract infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Gangrene</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="398"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Gastritis viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Gastroenteritis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Gastroenteritis viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Histoplasmosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Infected skin ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Infectious pleural effusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Influenza</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Intervertebral discitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Klebsiella bacteremia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Localized infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Necrotizing soft tissue infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Oral candidiasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Orchitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Oropharyngeal candidiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="398"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Osteomyelitis acute</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pancreatic abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pneumococcal sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="398"/>
                <counts group_id="E2" events="21" subjects_affected="21" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pneumonia haemophilus</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pneumonia staphylococcal</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Postoperative wound infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Psoas abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pyelonephritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pyelonephritis acute</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Respiratory tract infection viral</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="398"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Septic shock</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Serratia bacteremia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Sinusitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Staphylococcal infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Staphylococcal sepsis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Stenotrophomanas infection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Streptococcal bacteremia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Streptococcal sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Subcutaneous abscess</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Tracheobronchitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Tuberculosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Urinary tract infection bacterial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Urosepsis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Viral infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Viral sepsis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Abdominal wound dehiscence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Anemia postoperative</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Ankle fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Arteriovenous fistula occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Arteriovenous fistula site complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Arteriovenous fistula site hematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Arteriovenous graft thrombosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Eschar</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Femur fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Foot fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Fractured coccyx</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Fractured sacrum</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Gastrostomy failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Head injury</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hip fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Incision site hemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Limb surgery</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pneumothorax traumatic</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Post procedural complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Procedural hypotension</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Procedural pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pubis fracture</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pulmonary contusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Spinal compression fracture</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Subdural hematoma</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Toxicity to various agents</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Transplant dysfunction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Vascular access complication</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Vascular graft complication</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Investigations</title>
            <event_list>
              <event>
                <sub_title>Blood creatinine phosphokinase MB increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Blood culture positive</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Blood potassium increased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Ejection fraction increased</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hemoglobin decreased</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>International normalized ration increased</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Diabetes mellitus inadequate control</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Diabetic ketoacidosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Failure to thrive</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Fluid overload</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="398"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Gout</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hyperglycemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hyperkalemia</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="398"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hyperosmolar state</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hypoglycaemia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="398"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hypovolemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Lactic acidosis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Metabolic acidosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Metabolic disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Arthritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Costochondritis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Intervertebral disc degeneration</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Intervertebral disc protrusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Joint effusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Lumbar spinal stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Muscular weakness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Musculoskeletal chest pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Myopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Rotator cuff syndrome</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Spinal column stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Chronic lymphocytic leukemia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Lung neoplasm malignant</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Neoplasm malignant</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Small cell lung cancer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Urine leiomyoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Altered state of consciousness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Autonomic nervous system imbalance</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Carotid artery occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Carpal tunnel syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Cerebellar hemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Cerebellar stroke</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Cerebral hemorrhage</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Cerebral infarction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Cerebral ischemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Cerebrovascular accident</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="398"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Dementia</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Dizziness postural</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Guillain-Barre syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hemorrhage intracranial</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hemorrhagic stroke</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hepatic encephalopathy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hyperglycemic seizure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hypertensive encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hypoxic-ischemic encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Loss of consciousness</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Metabolic encephalopathy</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Neuralgia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Paraesthesia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Posterior reversible encephalopathy syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Seizure</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Somnolence</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Toxic encephalopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Transient ischemic attack</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Abortion spontaneous</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Device breakage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Device dislocation</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Device malfunction</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Thrombosis in device</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Delirium</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Suicidal ideation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Azotemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>End stage renal disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Nephrolithiasis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Renal failure</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Renal hematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Penile swelling</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Acute pulmonary oedema</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Acute respiratory distress syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Acute respiratory failure</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Asthma</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Bronchiectasis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Chronic obstructive pulmonary disease</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="398"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Dyspnea</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Dyspnea exertional</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Epistaxis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hemoptysis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hypoxia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pneumonia aspiration</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pneumonitis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pneumothorax</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pulmonary embolism</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pulmonary hypertension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pulmonary edema</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="398"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="398"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Decubitus ulcer</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Diabetic foot</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Swelling face</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Accelerated hypertension</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Angiopathy</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Aortic dissection</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Aortic stenosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Arterial hemorrhage</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Arteriosclerosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Dry gangrene</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Haematoma</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="398"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hypertensive crisis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hypertensive emergency</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="398"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Iliac artery occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Jugular vein thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Orthostatic hypotension</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Peripheral artery occlusive disease</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Peripheral artery occlusion</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Peripheral ischemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Peripheral vascular disorder</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Steal syndrome</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Superior vena cava occlusion</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="398"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Vasculitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Vasoconstriction</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Venous stenosis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="398"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>2</frequency_threshold>
        <default_vocab>MeDRA 21.0</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="314" subjects_at_risk="398"/>
                <counts group_id="E2" subjects_affected="315" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="398"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Nephrogenic anemia</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="398"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Acute myocardial infarction</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="398"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Angina pectoris</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="398"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Atrial fibrillation</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="398"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Bradycardia</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="398"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Cardiac failure congestive</sub_title>
                <counts group_id="E1" events="16" subjects_affected="16" subjects_at_risk="398"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Tachycardia</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="398"/>
                <counts group_id="E2" events="22" subjects_affected="22" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Abdominal pain</sub_title>
                <counts group_id="E1" events="20" subjects_affected="20" subjects_at_risk="398"/>
                <counts group_id="E2" events="27" subjects_affected="27" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Constipation</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="398"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Diarrhea</sub_title>
                <counts group_id="E1" events="38" subjects_affected="38" subjects_at_risk="398"/>
                <counts group_id="E2" events="30" subjects_affected="30" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Gastrointestinal hemorrhage</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="398"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Nausea</sub_title>
                <counts group_id="E1" events="26" subjects_affected="26" subjects_at_risk="398"/>
                <counts group_id="E2" events="43" subjects_affected="43" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Vomiting</sub_title>
                <counts group_id="E1" events="24" subjects_affected="24" subjects_at_risk="398"/>
                <counts group_id="E2" events="31" subjects_affected="31" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Asthenia</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="398"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Catheter site erythema</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="398"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Non-cardiac chest pain</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="398"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Edema peripheral</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="398"/>
                <counts group_id="E2" events="19" subjects_affected="19" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pain</sub_title>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="398"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Peripheral swelling</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="398"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pyrexia</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="398"/>
                <counts group_id="E2" events="24" subjects_affected="24" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Bacteremia</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="398"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Bronchitis</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="398"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Cellulitis</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="398"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Device-related infection</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="398"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Nasopharyngitis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="398"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Osteomyelitis</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="398"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pneumonia</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="398"/>
                <counts group_id="E2" events="28" subjects_affected="28" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Sepsis</sub_title>
                <counts group_id="E1" events="11" subjects_affected="11" subjects_at_risk="398"/>
                <counts group_id="E2" events="21" subjects_affected="21" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Upper respiratory tract infection</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="398"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Urinary tract infection</sub_title>
                <counts group_id="E1" events="12" subjects_affected="12" subjects_at_risk="398"/>
                <counts group_id="E2" events="15" subjects_affected="15" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Arteriovenous fistula site complication</sub_title>
                <counts group_id="E1" events="13" subjects_affected="13" subjects_at_risk="398"/>
                <counts group_id="E2" events="20" subjects_affected="20" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Fall</sub_title>
                <counts group_id="E1" events="17" subjects_affected="17" subjects_at_risk="398"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Procedural hypotension</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="398"/>
                <counts group_id="E2" events="18" subjects_affected="18" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Metabolism and nutrition disorders</title>
            <event_list>
              <event>
                <sub_title>Fluid overload</sub_title>
                <counts group_id="E1" events="26" subjects_affected="26" subjects_at_risk="398"/>
                <counts group_id="E2" events="21" subjects_affected="21" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hyperkalemia</sub_title>
                <counts group_id="E1" events="27" subjects_affected="27" subjects_at_risk="398"/>
                <counts group_id="E2" events="26" subjects_affected="26" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hypoglycemia</sub_title>
                <counts group_id="E1" events="14" subjects_affected="14" subjects_at_risk="398"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Back pain</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="398"/>
                <counts group_id="E2" events="17" subjects_affected="17" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Muscle spasm</sub_title>
                <counts group_id="E1" events="23" subjects_affected="23" subjects_at_risk="398"/>
                <counts group_id="E2" events="36" subjects_affected="36" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pain in extremity</sub_title>
                <counts group_id="E1" events="15" subjects_affected="15" subjects_at_risk="398"/>
                <counts group_id="E2" events="22" subjects_affected="22" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="22" subjects_affected="22" subjects_at_risk="398"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Headache</sub_title>
                <counts group_id="E1" events="22" subjects_affected="22" subjects_at_risk="398"/>
                <counts group_id="E2" events="22" subjects_affected="22" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Syncope</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="398"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Product Issues</title>
            <event_list>
              <event>
                <sub_title>Device dislocation</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="398"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Device malfunction</sub_title>
                <counts group_id="E1" events="68" subjects_affected="68" subjects_at_risk="398"/>
                <counts group_id="E2" events="47" subjects_affected="47" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Device occlusion</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="398"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Thrombosis in device</sub_title>
                <counts group_id="E1" events="8" subjects_affected="8" subjects_at_risk="398"/>
                <counts group_id="E2" events="16" subjects_affected="16" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Insomnnia</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="398"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Mental status changes</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="398"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Cough</sub_title>
                <counts group_id="E1" events="21" subjects_affected="21" subjects_at_risk="398"/>
                <counts group_id="E2" events="30" subjects_affected="30" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Dyspnea</sub_title>
                <counts group_id="E1" events="19" subjects_affected="19" subjects_at_risk="398"/>
                <counts group_id="E2" events="30" subjects_affected="30" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pleural effusion</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="398"/>
                <counts group_id="E2" events="10" subjects_affected="10" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Pulmonary edema</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="398"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Respiratory failure</sub_title>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="398"/>
                <counts group_id="E2" events="13" subjects_affected="13" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Skin and subcutaneous tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Skin ulcer</sub_title>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="398"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Hypertension</sub_title>
                <counts group_id="E1" events="27" subjects_affected="27" subjects_at_risk="398"/>
                <counts group_id="E2" events="39" subjects_affected="39" subjects_at_risk="399"/>
              </event>
              <event>
                <sub_title>Hypotension</sub_title>
                <counts group_id="E1" events="35" subjects_affected="35" subjects_at_risk="398"/>
                <counts group_id="E2" events="27" subjects_affected="27" subjects_at_risk="399"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Head of Clinical Operations</name_or_title>
      <organization>CorMedix Inc.</organization>
      <phone>908-517-9500</phone>
      <email>lmasson@cormedix.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

